Emcure Pharmaceuticals Limited (NSE:EMCURE)
India · Delayed Price · Currency is INR 1,863.00
-18.40 (-0.98%)
Aug 21, 2026, 3:29 PM IST
Emcure Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Emcure Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of ₹2,214. The average 1-year stock price forecast is 18.86% higher than the current stock price, while the lowest is ₹1,900 (+1.99%) and the highest is ₹2,362 (+26.78%).
Price Target: ₹2,214 (+18.86%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Emcure Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 4 | 5 | 5 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains ₹2,100 → ₹2,320 | Buy | Maintains | ₹2,100 → ₹2,320 | +24.53% | Aug 12, 2026 |
Financial Forecast
Revenue This Year
105.91B
from 92.04B
Increased by 15.08%
Revenue Next Year
119.53B
from 105.91B
Increased by 12.85%
EPS This Year
63.45
from 52.29
Increased by 21.34%
EPS Next Year
78.44
from 63.45
Increased by 23.64%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.